Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial
Gabriel N. Hortobágyi, Aleksandra Łacko, Joohyuk Sohn, F. Melo Cruz, Manuel Ruíz Borrego, Alexey Manikhas and 23 more
- Rank
- 21 of 3,853
- Percentile
- top 0.6%
- Where
- Annals of Oncology, 2024
- Citations
- 112
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.